3

3SBio
1530

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$54.97B
EV
HK$54.79B
Shares Outstanding
2.37B
Beta
0.76

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$17.53
P/E 2025E
21.58x
P/Revenue 2025E
3.64x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About 3SBio Inc.

gainify

3

3SBio Inc.

1530

3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thro...

Sector

Healthcare

Industry

Biotechnology

CEO

Lou, Jing

Employees

5,577

IPO Date

2015-06-11

Headquarters

No. 3 A1, Road 10, Shenyang Economy and Technology Developm, Shenyang, Liaoning Province China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.